Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Dianthus Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2019 · IPO 2023 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$4.14B
Market cap · Apr/2026
Revenue
$2.0M
Latest reported FY

Investors

19 investors on Dianthus Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 7 investors entered at this stage
Fairmount Funds Management
5AM Ventures
Avidity Partners
Venrock Healthcare Capital Partners
Fidelity Investments
Tellus BioVentures
Wedbush Morgan Securities
Series B+ 12 investors entered at this stage
Logos Capital
Great Point Partners
RA Capital Management
StemPoint Capital
Ally Bridge Group
RTW Investments
Logos Capital Group
Catalio Capital Management
Octagon Capital Advisors
Woodline Partners
Vestal Point Capital
Bain Capital Life Sciences

Global footprint

Where Dianthus Therapeutics has talent and traffic

Web traffic by country
11K monthly visits
across markets
🇺🇸 United States75.5%
🇮🇳 India20%
🇫🇷 France4.5%
Top 3 markets shown

See Dianthus Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo